American journal of kidney diseases : the official journal of the National Kidney Foundation
-
Albuminuria is an important sign of chronic kidney disease and is detected routinely by measurement of urinary albumin-creatinine ratio (ACR). A Siemens CLINITEK test designed for use at the point of care is available that can semiquantitatively measure ACR. ⋯ The instrument-read reagent strip test was a poor rule-in test for albuminuria at the point of care, as evidenced by the low positive predictive value, but was a reasonable rule-out test. Observed sensitivity was lower than reported in earlier laboratory-based studies. This decreased diagnostic accuracy needs to be balanced against the potential advantages of a point-of-care testing approach.
-
In 2007, the National Kidney Foundation (NKF) published clinical practice guidelines and recommendations for treating patients with diabetes and kidney diseases. Given recent studies that may enhance our understanding of the benefits and harms of glycemic, lipid, and albuminuria management in patients with diabetes and chronic kidney disease (CKD), the NKF commissioned a systematic review to evaluate data on the management of these patients. ⋯ Intensive glycemic control and lipid interventions did not improve clinical outcomes in patients with type 2 diabetes. Although interventions typically improved albuminuria, evidence was insufficient to determine whether treatment of albuminuria in normotensive patients provides beneficial effects on clinical outcomes. More intensive clinical management of patients with diabetes and CKD has inherent risks, including severe hypoglycemia, which should be considered when formulating treatment strategies.
-
Despite the high prevalence and enormous public health implications of chronic kidney disease (CKD), the factors responsible for its development and progression are incompletely understood. To date, only a few studies have attempted to objectively characterize sleep in patients with CKD prior to kidney failure, but emerging evidence suggests a high prevalence of sleep disorders, particularly obstructive sleep apnea. Laboratory and epidemiologic studies have shown that insufficient sleep and poor sleep quality promote the development and exacerbate the severity of 3 important risk factors for CKD, namely hypertension, type 2 diabetes, and obesity. ⋯ The negative impact of sleep disorders on vascular compliance and endothelial function also may have a deleterious effect on CKD. Sleep disturbances therefore may represent a novel risk factor for the development and progression of CKD. Optimizing sleep duration and quality and treating sleep disorders may reduce the severity and delay the progression of CKD.
-
Case Reports
Nonocclusive mesenteric ischemia in a dialysis patient with extensive vascular calcification.
We describe a case of nonocclusive mesenteric ischemia in a 37-year-old man with hemodialysis-dependent chronic kidney disease due to diabetes who was admitted to our hospital with abdominal pain. A plain radiograph of the abdomen showed distended loops of small bowel and gas in the hepatic portal vein. Multidetector computed tomography showed massive wall calcification of the superior mesenteric artery and its collaterals, pneumatosis intestinalis of a segment of the jejunum, and porto-mesenteric vein gas. ⋯ Pathologic examination showed whole-layer necrosis of the resected bowel without arterial or venous thrombosis. Nonocclusive mesenteric ischemia is an increasingly recognized and potentially lethal complication in hemodialysis patients. In the present case, critical factors for the development of nonocclusive mesenteric ischemia may have included prolonged hypotension during hemodialysis treatments that reduced blood flow to the small bowel and massive vascular calcification that negatively affected compliance of the superior mesenteric artery and its branches.